Clinical trial
Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV…
NCT00005825 · Raghu Nandan, M.D., Inc, Other · Unknown status
Key facts
| NCT number | NCT00005825 |
|---|---|
| Title | Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer |
| Official title | Trans Retinoic Acid (Vesanoid) With Chemotherapy in Non-Small Cell Lung Cancer |
| Lead sponsor | Raghu Nandan, M.D., Inc, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug |
| Interventions | cisplatin, mitomycin C, tretinoin, vinorelbine tartrate |
| Start date | Sep 1, 1998 |
| First posted | Jan 27, 2003 |
| Last update posted | Dec 18, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: